Tolerability of Ramipril in High Doses and Its Comparative Effects (In Combination with Hydrochlorothiazade) with Felodipine Extended Release on Mild to Moderate Hypertension in Nigerian Africans

Author(s):  
OO Ogunleye ◽  
AK Adebayo ◽  
AA Adebiyi ◽  
CO Falade ◽  
AO Falase
1991 ◽  
Vol 12 (5) ◽  
pp. 275-281 ◽  
Author(s):  
Anno Wester ◽  
A. Ross Lorimer ◽  
Berit Westberg

2020 ◽  
Vol 2020 ◽  
pp. 1-2
Author(s):  
Joseph Kuo ◽  
Shih-Ku Lin

Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole.


1991 ◽  
Vol 68 (5) ◽  
pp. 457-462 ◽  
Author(s):  
Gino Santoro ◽  
Stefano Savonitto ◽  
Vito Di Bello ◽  
Daniele Alberti ◽  
Costantino Giusti

Sign in / Sign up

Export Citation Format

Share Document